Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sézary”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Ended earlyNCT00490776
What this trial is testing

Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T-Cell Lymphoma
Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT02822586
What this trial is testing

TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome

Who this might be right for
Mycosis FungoidesSézary Syndrome
Virginia Commonwealth University 5
Not applicableActive Not RecruitingNCT05455931
What this trial is testing

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

Who this might be right for
Mycosis Fungoides and Sézary Syndrome
Kyowa Kirin Pharmaceutical Development Ltd 73
Testing effectiveness (Phase 2)Study completedNCT03063632
What this trial is testing

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

Who this might be right for
Metastatic Myxoid LiposarcomaMetastatic Round Cell LiposarcomaMetastatic Synovial Sarcoma+13 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT02953301
What this trial is testing

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

Who this might be right for
Mycosis FungoidesSezary SyndromeLymphoma, T-Cell, Cutaneous
4SC AG 201
Not applicableLooking for participantsNCT04904146
What this trial is testing

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

Who this might be right for
Mycosis FungoidesSezary Syndrome
Lund University Hospital 120
Early research (Phase 1)Ended earlyNCT00369629
What this trial is testing

Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Lymphoma
Northwestern University 14
Not applicableStudy completedNCT02836886
What this trial is testing

VircapSeq Virus Detection in Sézary Syndrome

Who this might be right for
Lymphoma, T-Cell, CutaneousSézary Syndrome
Columbia University 6
Not applicableLooking for participantsNCT05157581
What this trial is testing

Extracorporeal Photopheresis in Sezary Syndrome

Who this might be right for
Sezary Syndrome
Oleg E. Akilov, MD, PhD 20
Testing effectiveness (Phase 2)Study completedNCT00425555
What this trial is testing

Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-Cell Lymphoma
Novartis Pharmaceuticals 139
Testing effectiveness (Phase 2)Active Not RecruitingNCT04960618
What this trial is testing

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Mycosis FungoidesMycosis Fungoides/Sezary SyndromeSezary Syndrome+2 more
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00306969
What this trial is testing

Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-Cell Lymphoma
Boston University 18
Testing effectiveness (Phase 2)Study completedNCT01396070
What this trial is testing

Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Cutaneous LymphomaCutaneous T-cell Lymphoma (CTCL)+2 more
Youn Kim 36
Large-scale testing (Phase 3)Ended earlyNCT02811783
What this trial is testing

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Who this might be right for
Mycosis FungoidesLymphoma, T-Cell, CutaneousSézary Syndrome
Elorac, Inc. 59
Not applicableLooking for participantsNCT07003100
What this trial is testing

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Who this might be right for
Recurrent Mycosis FungoidesRecurrent Sezary SyndromeRefractory Mycosis Fungoides+6 more
City of Hope Medical Center 100
Early research (Phase 1)WithdrawnNCT03617224
What this trial is testing

Pembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary Syndrome

Who this might be right for
Cutaneous T-Cell Lymphomas
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT00969085
What this trial is testing

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

Who this might be right for
Cutaneous T-cell Lymphoma
M.D. Anderson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT04652960
What this trial is testing

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

Who this might be right for
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT00057967
What this trial is testing

Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Lymphoma
Northwestern University 37
Early research (Phase 1)Study completedNCT00554827
What this trial is testing

Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc. 55
Load More Results